Are animal models predictive for humans?

Sarewitz D, Pielke RA: Prediction in Science and Policy. Prediction: Science, Decision Making, and the Future of Nature. Edited by: Sarewitz D, Pielke RA Jr, Byerly R Jr. 2000, 11-22. Island Press, Quine W: Quiddities" An Intermittently Philosophical Dictionary. 2005, Cambridge: The Belknap Press of Harvard University Press, LaFollette H, Shanks N: Brute Science: Dilemmas of animal experimentation. 1996, London and New York: Routledge, Greek R, Greek J: Specious Science. 2002, New York: Continuum Int, Xceleron. http://www.xceleron.com/metadot/index.pl Altman L: Who Goes First? The Story of Self-Experimentation in Medicine. 1998, University of California Press, Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S, de Stahl TD, Menzel U, Sandgren J, von Tell D, Poplawski A, Crowley M, Crasto C, Partridge EC, Tiwari H, Allison DB, Komorowski J, van Ommen GJ, Boomsma DI, Pedersen NL, den Dunnen JT, Wirdefeldt K, Dumanski JP: Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet. 2008, 82: 763-771. 10.1016/j.ajhg.2007.12.011 Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M: Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 2005, 102: 10604-10609. 10.1073/pnas.0500398102 Weiss ST, McLeod HL, Flockhart DA, Dolan ME, Benowitz NL, Johnson JA, Ratain MJ, Giacomini KM: Creating and evaluating genetic tests predictive of drug response. Nat Rev Drug Discov. 2008, 7: 568-574. 10.1038/nrd2520 Kaiser J: Gender in the pharmacy: does it matter?. Science. 2005, 308: 1572- 10.1126/science.308.5728.1572 Willyard C: Blue's clues. Nat Med. 2007, 13: 1272-1273. 10.1038/nm1107-1272 Couzin J: Cancer research. Probing the roots of race and cancer. Science. 2007, 315: 592-594. 10.1126/science.315.5812.592 Holden C: Sex and the suffering brain. Science. 2005, 308: 1574- 10.1126/science.308.5728.1574 Salmon W: Rational Prediction. Philosophy of Science. Edited by: Curd M, Cover J, Norton. 1998, 433-444. Butcher EC: Can cell systems biology rescue drug discovery?. Nat Rev Drug Discov. 2005, 4: 461-467. 10.1038/nrd1754 Horrobin DF: Modern biomedical research: an internally self-consistent universe with little contact with medical reality?. Nat Rev Drug Discov. 2003, 2: 151-154. 10.1038/nrd1012 Pound P, Ebrahim S, Sandercock P, Bracken MB, Roberts I: Where is the evidence that animal research benefits humans?. BMJ. 2004, 328: 514-517. 10.1136/bmj.328.7438.514 Editorial: The time is now. Nat Rev Drug Discov. 2005, 4: 613 Littman BH, Williams SA: The ultimate model organism: progress in experimental medicine. Nat Rev Drug Discov. 2005, 4: 631-638. 10.1038/nrd1800 Uehling M: Microdoses of Excitement over AMS, 'Phase 0' Trials. Bio-IT World. 2006, 2006: Dixit R, Boelsterli U: Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies. Drug Discovery Today. 2007, 12: 336-342. 10.1016/j.drudis.2007.02.018 Greek R, Greek J: Sacred Cows and Golden Geese: The Human Cost of Experiments on Animals. 2000, New York: Continuum Int, Greek J, Greek R: What Will We Do if We Don't Experiment on Animals. Continuum. 2004, FDA Issues Advice to Make Earliest Stages Of Clinical Drug Development More Efficient. http://www.fda.gov/bbs/topics/news/2006/NEW01296.html Knight A: The beginning of the end for chimpanzee experiments?. Philos Ethics Humanit Med. 2008, 3: 16- 10.1186/1747-5341-3-16 Shanks N, Pyles RA: Evolution and medicine: the long reach of "Dr. Darwin". Philos Ethics Humanit Med. 2007, 2: 4- 10.1186/1747-5341-2-4 Vineis P, Melnick R: A Darwinian perspective: right premises, questionable conclusion. A commentary on Niall Shanks and Rebecca Pyles' "evolution and medicine: the long reach of "Dr. Darwin"". Philos Ethics Humanit Med. 2008, 3: 6- 10.1186/1747-5341-3-6 Debate title: Animals are predictive for humans. http://video.google.com/videoplay?docid=-8464924004908818871%26q=madison+debate+animal%26total=5%26start=0%26num=30%26so=0%26type=search%26plindex=0 Gad S: Preface. Animal Models in Toxicology. Edited by: Gad S. 2007, 1-18. CRC Press, Fomchenko EI, Holland EC: Mouse models of brain tumors and their applications in preclinical trials. Clin Cancer Res. 2006, 12: 5288-5297. 10.1158/1078-0432.CCR-06-0438 Hau J: Animal Models. Handbook of Laboratory Animal Science Animal Models. Edited by: Hau J, van Hoosier GK Jr. 2003, II: 2-8. CRC Press, 2, Staff: Of Mice...and Humans. Drug Discovery and Development. 2008, 11: 16-20. FDA panel recommends continued use of controversial diabetes drug. http://www.cnn.com/HEALTH/9903/26/rezulin.review.02/index.html Masubuchi Y: Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review. Drug Metab Pharmacokinet. 2006, 21: 347-356. 10.2133/dmpk.21.347 Topol EJ: Failing the public health – rofecoxib, Merck, and the FDA. N Engl J Med. 2004, 351: 1707-1709. 10.1056/NEJMp048286 Heywood R: Clinical Toxicity – Could it have been predicted? Post-marketing experience. Animal Toxicity Studies: Their Relevance for Man. Edited by: Lumley CE, Walker S Lancaster, Quay. 1990, 57-67. Spriet-Pourra C, Auriche M: Drug Withdrawal from Sale. New York. 1994, 2, Igarashi T: The duration of toxicity studies required to support repeated dosing in clinical investigation – A toxicologists opinion. CMR Workshop: The Timing of Toxicological Studies to Support Clinical Trials. Edited by: Parkinson CNM, Lumley C, Walker SR. 1994, 67-74. Boston/UK: Kluwer, Sankar U: The Delicate Toxicity Balance in Drug Discovery. The Scientist. 2005, 19: 32- Wilbourn J, Haroun L, Heseltine E, Kaldor J, Partensky C, Vainio H: Response of experimental animals to human carcinogens: an analysis based upon the IARC Monographs programme. Carcinogenesis. 1986, 7: 1853-1863. 10.1093/carcin/7.11.1853 Rall DP: Laboratory animal tests and human cancer. Drug Metab Rev. 2000, 32: 119-128. 10.1081/DMR-100100565 Tomatis L, Aitio A, Wilbourn J, Shuker L: Human carcinogens so far identified. Jpn J Cancer Res. 1989, 80: 795-807. Knight A, Bailey J, Balcombe J: Animal carcinogenicity studies: 1. Poor human predictivity. Altern Lab Anim. 2006, 34: 19-27. Tomatis L, Wilbourn L: Evaluation of carcinogenic risk to humans: the experience of IARC. New Frontiers in Cancer Causation. Edited by: Iversen. 2003, 371-387. Washington, DC: Taylor and Francis, IARC: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 1972, Lyon: IARC, IARC monographs programme on the evaluation of carcinogenic risks to humans. http://monographs.iarc.fr Haseman JK: Using the NTP database to assess the value of rodent carcinogenicity studies for determining human cancer risk. Drug Metab Rev. 2000, 32: 169-186. 10.1081/DMR-100100570 Gold LS, Slone TH, Ames BN: What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. Drug Metab Rev. 1998, 30: 359-404. 10.3109/03602539808996318 Freeman M, St Johnston D: Wherefore DMM?. Disease Models & Mechanisms. 2008, 1: 6-7. 10.1242/dmm.000760 Schardein J: Drugs as Teratogens. 1976, CRC Press, Schardein J: Chemically Induced Birth Defects. Marcel Dekker. 1985, Manson J, Wise D: Teratogens. Casarett and Doull's Toxicology. 1993, 228-4, Caldwell J: Comparative Aspects of Detoxification in Mammals. Enzymatic Basis of Detoxification. Edited by: Jakoby W. 1980, 1: New York: Academic Press, Runner MN: Comparative pharmacology in relation to teratogenesis. Fed Proc. 1967, 26: 1131-1136. Keller SJ, Smith MK: Animal virus screens for potential teratogens. I. Poxvirus morphogenesis. Teratog Carcinog Mutagen. 1982, 2: 361-374. 10.1002/1520-6866(1990)2:3/4<361::AID-TCM1770020318>3.0.CO;2-I Staples RE, Holtkamp DE: Effects of Parental Thalidomide Treatment on Gestation and Fetal Development. Exp Mol Pathol. 1963, 26: 81-106. Caldwell J: Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolism. Toxicol Lett. 1992, 64–65 (Spec No): 651-659. 10.1016/0378-4274(92)90244-E. 10.1016/0378-4274(92)90244-E Wall RJ, Shani M: Are animal models as good as we think?. Theriogenology. 2008, 69: 2-9. 10.1016/j.theriogenology.2007.09.030 Curry SH: Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? A theory based on allometric relationships. Ann N Y Acad Sci. 2003, 993: 69-74. discussion 79–81, Shubick P: Statement of the Problem. Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis. Edited by: Coulston F, Shubick P. 1980, 5-17. Ablex Pub, Coulston F: Final Discussion. Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis. Edited by: Coulston F, Shubick P. 1980, 407-Ablex, Council_on_Scientific_Affairs: Carcinogen regulation. JAMA. 1981, 246: 253-256. 10.1001/jama.246.3.253 Salsburg D: The lifetime feeding study in mice and rats – an examination of its validity as a bioassay for human carcinogens. Fundam Appl Toxicol. 1983, 3: 63-67. 10.1016/S0272-0590(83)80174-2 , : IARC Working group on the evaluation of carcinogenic risks to humans. Lyon. 1972, 1–78: Sloan DA, Fleiszer DM, Richards GK, Murray D, Brown RA: Increased incidence of experimental colon cancer associated with long-term metronidazole therapy. Am J Surg. 1983, 145: 66-70. 10.1016/0002-9610(83)90168-X Clemmensen J, Hjalgrim-Jensen S: On the absence of carcinogenicity to man of phenobarbital. Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis. Edited by: Alex Pub. 1980, 251-265. Coulston F, Shubick S, Clayson D: The carcinogenic action of drugs in man and animals. Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis. Edited by: Coulston F, Shubick P. 1980, 185-195. Ablex Pub, Anisimov V: Carcinogenesis and Aging. 1987, Boca Rotan: CRC Press, Anisimov V: Molecular and Physiological Mechanisms of Aging. 2003, St Petersburg: Nauka, Dilman VM, Anisimov VN: Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice. Gerontology. 1980, 26: 241-246. IARC: Some aromatic amines, hydrazine and related substances, n-nitroso compounds and miscellaneous alkylating agents. IARC monograph on the evaluation of carcinogenic risks to humans, Lyon. 1974, 4: Anisimov VN, Ukraintseva SV, Yashin AI: Cancer in rodents: does it tell us about cancer in humans?. Nat Rev Cancer. 2005, 5: 807-819. 10.1038/nrc1715 Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nat Rev Cancer. 2002, 2: 331-341. 10.1038/nrc795 Rangarajan A, Weinberg RA: Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer. 2003, 3: 952-959. 10.1038/nrc1235 Anisimov VN: Age as a risk in multistage carcinogenesis. Comprehensive Geriatric Oncology. Edited by: Balducci L, Ershler WB, Lyman GH. 2004, 75-101. 157–178, M E: Informa Healthcare. Taylor and Francis group, 2, Overmier JB, Carroll ME: Basic Issues in the Use of Animals in Health Research. Animal Research and Human Health. Edited by: Carroll ME, Overmier JB. 2001, 5-American Psychological Association, Kolata G: 2 Top Diet Drugs Are Recalled Amid Reports of Heart Defects. New York Times. New York. 1997, Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A: Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000, 32: 56-67. 10.1006/rtph.2000.1399 Shanks N, Greek R, Nobis N, Greek J: Animals and Medicine: Do Animal Experiments Predict Human Response?. Skeptic. 2007, 13: 44-51. Conn P, Parker J: Letter. Animal research wars. Skeptic. 2007, 13: 18-19. Van Regenmortel MH: Reductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism. EMBO Rep. 2004, 5: 1016-1020. 10.1038/sj.embor.7400284 Morange M: A successful form for reductionism. The Biochemist. 2001, 23: 37-39. Morange M: The misunderstood gene. 2001, Cambridge: Harvard University Press, Mepham TB, Combes RD, Balls M, Barbieri O, Blokhuis HJ, Costa P, Crilly RE, de Cock Buning T, Delpire VC, O'Hare MJ, Houdebine LM, van Kreijl CF, Meer van der M, Reinhardt CA, Wolf E, van Zeller AM: The Use of Transgenic Animals in the European Union: The Report and Recommendations of ECVAM Workshop 28. Altern Lab Anim. 1998, 26: 21-43. Liu Z, Maas K, Aune TM: Comparison of differentially expressed genes in T lymphocytes between human autoimmune disease and murine models of autoimmune disease. Clin Immunol. 2004, 112: 225-230. 10.1016/j.clim.2004.03.017 Dennis C: Cancer: off by a whisker. Nature. 2006, 442: 739-741. 10.1038/442739a Houdebine LM: Transgenic animal models in biomedical research. Methods Mol Biol. 2007, 360: 163-202.